AMPLION FOR DIAGNOSTICS

Product Portfolio Strategic Planning

Amplion leverages sophisticated machine learning to collect, analyze, and categorize biomarker intelligence.  Access to the comprehensive evidence landscape allows us to develop and justify your overall product portfolio strategy and support the following activities with the highest confidence:

 

  • Trending Biomarker Identification

  • Technology Alignment

  • Product Design Refinement

  • Strategic Partnership Opportunities

  • Regulatory Predicate Identification & Validation

  • Competitive Intel

DOWNLOAD COMMERCIAL TRENDS REPORT

Amplion’s Benefits By Role

  • PRODUCT MANAGEMENT / PORTFOLIO STRATEGY:Gain timely and actionable biomarker competitive insights and market landscapes that drives successful product strategies. Get the information you need to ensure your portfolio is aligned with what the market needs.

  • COMPETITIVE INTELLIGENCE:Gain timely and actionable competitive biomarker insights that drive successful strategies. See what your key competitors are up to as it relates to traditional, companion and complementary diagnostic development.

  • MARKETING:Gain timely and actionable biomarker competitive insights and market landscapes that drive successful marketing strategies and tactics including thought leadership and lead generation.

  • BUSINESS DEVELOPMENT:Gain timely and actionable partnering insights and market landscapes that drive biomarker partnerships for market success.

GET A DEMO

Commercial Success

Ensure a product portfolio mix that aligns with strong, validated trends in technical requirements and customer needs.

COMMERCIAL TRENDS REPORT

Solutions for Diagnostics

biomarkerbase-self-service-icon.png

PRODUCT STRATEGY SOLUTIONS

Leverage our deep expertise in the development of evidence-based product portfolio strategic plans. Our access to proprietary and public datasets gives us a unique ability to drive your product strategies.

 

> LEARN MORE

solutions-for-diagnostics.png

BIOMARKERBASE™

A web-based, self-service biomarker intelligence solution providing a comprehensive landscape of clinical biomarker usage and emerging or novel biomarkers. BiomarkerBase keeps your focus on the most evidence-based, well-validated and commercially viable opportunities.

 

> LEARN MORE

CUSTOMER SUCCESS
CUSTOMER SUCCESS STORIES

Resources

Success in Precision Medicine 

Concise Guidance for Biopharma & Diagnostics Developers

The growing importance of biomarkers in precision medicine

Health Decisions reports that an early focus on clinical validation of biomarkers is one of nine key steps to securing a winning position in the development of precision medicine.

Commercial Trends Report

Market Trends for Biomarker-based IVD Tests

New Call-to-action

This free report covers:

  • Annual test releases and review periods
  • Novelty of biomarkers in tests
  • Biomarker panels
  • Companion disgnostic test development
  • Companies involved in test development

Precision Medicine Scorecard

New Call-to-action

The precision medicine scorecard provides a ranking of companies in precision medicine.